Vera Therapeutics is trading 4.38% lower at $34.67 as rising crude oil and Treasury yields weigh on equity valuations. - The Nasdaq Composite is down 1.16% and the S&P 500 is down 0.57%. - No fresh company-specific negative catalyst was identified on September 23, 2026. Recent TRUTAKNA ORIGIN 3 results were positive, making them unlikely to explain today’s decline.